National Cancer Centre, Singapore clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 116 studies whose lead sponsor is National Cancer Centre, Singapore. 29 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 20, 2026.
Keep track of what changes. Save the National Cancer Centre, Singapore studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Focus areas
Conditions National Cancer Centre, Singapore leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 116. Browse all 116 →
- Histotripsy for Ablation of Liver Tumours in AsiaRecruitingNCT07428356Not applicable
- Effectiveness and Implementation of 'Supportive and Palliative Care Review Kit in Locations Everywhere'Not yet recruitingNCT07745816Not applicable
- Mailed FIT-Based Outreach InterventionsNot yet recruitingNCT07852793Not applicable
- Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRCRecruitingNCT04912765Phase 2
- Effectiveness, Acceptability and Feasibility of a Communication and Care Coordinator (CCC) Model in Facilitating Serious Illness Communication (SIC) and Care in Patients With CancerNot yet recruitingNCT07733973Not applicable
- Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early DementiaRecruitingNCT07234357Not applicable
- Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative CareRecruitingNCT06244953Not applicable
- Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Immunotherapy Alone or in Combination With ChemotherapyRecruitingNCT06587295Phase 1
- Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)Not yet recruitingNCT07521670Phase 2
- Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular CarcinomaRecruitingNCT05516628Phase 2
- Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer PatientsRecruitingNCT05929885Phase 2
- Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in SingaporeRecruitingNCT07116161Not applicable
- Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy.RecruitingNCT06766058Not applicable
- SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)RecruitingNCT05724264Not applicable
- Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver CancerNot yet recruitingNCT07111130Not applicable
- Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) ProjectRecruitingNCT02806388
- Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMPACT-INSPIRE)RecruitingNCT06956248
- Electroacupuncture for Cognitive Toxicity in Cancer Survivors: Assessing Implementation, Cost, and Effectiveness for IntegrationNot yet recruitingNCT07583979Phase 3
- Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG)RecruitingNCT06044441Not applicable
- Telegenetics or In-Person Genetic CounsellingRecruitingNCT04738708
- Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal CarcinomaRecruitingNCT06093061Phase 2
- Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research ProposalRecruitingNCT06977360Not applicable
- Breast Cancer Exercise Intervention StudyRecruitingNCT05957068Not applicable
- Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell LymphomaRecruitingNCT06160843Phase 2
- Using QPOP to Predict Treatment for Sarcomas and MelanomasRecruitingNCT04986748
- A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLCRecruitingNCT06418412
- Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer PatientsRecruitingNCT04340024
- tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)RecruitingNCT05517135
- Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic AdenocarcinomaRecruitingNCT04303403Phase 1
- Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC PatientsActive, not recruitingNCT05377034Phase 2
- Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular CarcinomaActive, not recruitingNCT05148572
- Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)Active, not recruitingNCT04965259
- Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With LetrozoleActive, not recruitingNCT05286437Phase 2
- A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLCActive, not recruitingNCT05773092Phase 2
- Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal CarcinomaActive, not recruitingNCT03097939Phase 2
- Increasing Uptake of Cascade Testing in Families With Familial Cancer Syndromes: A Randomized Controlled Trial of a Registry-aided Model.CompletedNCT07626814Not applicable
- Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-inSuspendedNCT05198479Phase 2
- Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLCCompletedNCT04087473
- Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular CarcinomaCompletedNCT03033446Phase 2
- PIPAC for Peritoneal MetastasesSuspendedNCT04956068Phase 1
- Molecular Profiling ProjectSuspendedNCT04025515
- Phase II Study of PRL3-ZUMAB in Advanced Solid TumorsCompletedNCT04118114Phase 2
- Acceptability and Feasibility of PSC Model of Serious Illness CommunicationActive, not recruitingNCT07428655Not applicable
- Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCCCompletedNCT06294808
- Window of Opportunity Study in Colorectal CancerCompletedNCT03984578Phase 2
- Impacts of Durian Consumption on Human Microbiome and Metabolome in Healthy Staff VolunteersCompletedNCT06194084Not applicable
- The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBCCompletedNCT04664829Phase 1
- Phase II Study to Assess the Efficacy of ASLAN001 Plus Capecitabine in CNS Metastases for HER2+ Breast CancerTerminatedNCT07166367Phase 2
- ENABLE (Educate, Nurture, Advise, Before Life Ends) Intervention for Heart Failure (HF) Patients and Their Caregivers in SingaporeCompletedNCT05211882Not applicable
- PSMA-PET Imaging of Salivary Gland Tumours and Other Rare CancersCompletedNCT05581979